Co-expression of CD39 and CD103 identifies tumor-reactive CD8 tumor-infiltrating lymphocytes in human solid tumors

immuneACCESS ◽  
2018 ◽  
Author(s):  
T Duhen ◽  
R Duhen ◽  
R Montler ◽  
J Moses ◽  
T Moudgil ◽  
...  
1995 ◽  
Vol 14 (2) ◽  
pp. 119-131 ◽  
Author(s):  
Peter S. Goedegebuure ◽  
Timothy J. Eberlein

1986 ◽  
Vol 90 (2) ◽  
pp. 221-233 ◽  
Author(s):  
Theresa L. Whiteside ◽  
Sylvia Miescher ◽  
H.R. MacDonald ◽  
V. Von Fliedner

2019 ◽  
Vol 343 ◽  
pp. 103753 ◽  
Author(s):  
Giuseppe Badalamenti ◽  
Daniele Fanale ◽  
Lorena Incorvaia ◽  
Nadia Barraco ◽  
Angela Listì ◽  
...  

2019 ◽  
Author(s):  
Richard C. Sainson ◽  
Miha Kosmac ◽  
Rachael Kimber ◽  
Joana Carvalho ◽  
Gwenoline Bohris ◽  
...  

2016 ◽  
Vol 21 (1-2) ◽  
pp. 51-54 ◽  
Author(s):  
Tat’yana N. Zabotina ◽  
O. V Korotkova ◽  
A. A Borunova ◽  
D. V Tabakov ◽  
I. I Bokin ◽  
...  

For the first time in Russia the immunophenotype of tumor infiltrated lymphocytes (TIL) was investigated with the use of a method of quantitative flow cytometry. Samples from 104 patients, suffering from solid tumors (such as breast cancer, ovarian cancer, melanoma and oral cavity squamous carcinoma), were analyzed in this investigation. In the difference of cytomorphological analysis, the method of flow cytometry identified TIL in 100% of cases. In the structure of CDS+Т- lymphocytes the ratio CD4/CD8 was equal to 1,1±0,1. Serial gating strategy allowed to assess minor subpopulations of regulatory T-lymphocytes CD45+CD4+CD127+low/neg and CD45+CD8+CD28-CD11b-. Regulatory mechanisms with involvement of CD8 T-cells played the main role in the generation of immune responses at the tissue level ofpatients, suffering from solid tumors, independent of nosological form of disease.


1992 ◽  
Vol 22 (3) ◽  
pp. 679-687 ◽  
Author(s):  
Masanobu Nanno ◽  
Hidetoshi Seki ◽  
George Mathioudaki ◽  
Ryuzi Suzuki ◽  
Kyogo Itoh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document